Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）

A Study on Multimodal Data Prediction of Outcome to Neoadjuvant Therapy in NSCLC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07388771

Enrollment

500

Registered

2026-02-05

Start date

2025-12-01

Completion date

2026-10-01

Last updated

2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoadjuvant Therapy, NSCLC

Brief summary

This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC. The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. pathologically diagnosed non-small cell lung cancer 2. The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection

Exclusion criteria

1. recurrent or metastatic lung cancer; 2. patients with other primary tumors

Design outcomes

Primary

Measure	Time frame
pathologic response	Perioperative

Secondary

Measure	Time frame	Description
EFS	One year after the treatment ended	event free survival

Countries

China

Contacts

CONTACTMinghao Hu

huminghao2010@126.com8613396366466

Outcome results